Evidence map›Paper›PMID 29068155›Full record

Trial reportAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2018

Longitudinal assessment of T cell inhibitory receptors in liver transplant recipients and their association with posttransplant infections.

Krupa R Mysore, Rafik M Ghobrial, Sunil Kannanganat, Laurie J Minze, Edward A Graviss, Duc T Nguyen, Katherine K Perez, Xian C Li

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Krupa R MysoreDivision of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Rafik M GhobrialImmunobiology & Transplant Science Center, Houston Methodist Hospital, Houston, TX, USA.
Sunil KannanganatImmunobiology & Transplant Science Center, Houston Methodist Hospital, Houston, TX, USA.
Laurie J MinzeImmunobiology & Transplant Science Center, Houston Methodist Hospital, Houston, TX, USA.
Edward A GravissDepartment of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX, USA.
Duc T NguyenDepartment of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX, USA.
Katherine K PerezDepartment of Pharmacy, Houston Methodist Hospital, Houston, TX, USA.
Xian C LiImmunobiology & Transplant Science Center, Houston Methodist Hospital, Houston, TX, USA.
Methodist Hospital · USHouston Methodist · USCornell University · US

Funding

Research Training in Pediatrics GastroenterolgyT32DK007664 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI DOUGLAS G BURRIN · 1991 to 2026
$8.4M
T cell fate decisions and transplant outcomesR56AI129906 · NIAID · METHODIST HOSPITAL RESEARCH INSTITUTE · PI LI, XIAN CHANG · 2017 to 2017
$402k
NIAID NIH HHS R56 AI129906NIDDK NIH HHS T32 DK007664
6 · The paper itself

Abstract

Current immunosuppression regimens in organ transplantation primarily inhibit T cells. However, T cells are also critical in protective immunity, especially in immune-compromised patients. In this study, we examined the association of T cell dysfunction, as marked by expression of T cell exhaustion molecules, and posttransplant infections in a cohort of liver transplant patients. We focused on Programmed Death 1 (PD-1) and T cell Ig- and mucin-domain molecule 3 (Tim-3), which are potent co-inhibitory receptors, and their persistent expression often leads to T cell dysfunction and compromised protective immunity. We found that patients with the highest expression of PD-1 +Tim-3+ T cells in the memory compartment before transplantation had increased incidence of infections after liver transplantation, especially within the first 90 days. Longitudinal analysis in the first year showed a strong association between variability of PD-1 and Tim-3 expression by T cells and infectious episodes in transplant patients. Furthermore, T cells that expressed PD-1 and Tim-3 had a significantly reduced capacity in producing interferon (IFN)-γ in vitro, and this reduced IFN-γ production could be partially reversed by blocking PD-1 and Tim-3. Interestingly, the percentage of Foxp3+ regulatory T cells in liver transplant patients was stable in the study period. We concluded that the functional status of T cells before and after liver transplantation, as shown by PD-1 and Tim-3 expression, may be valuable in prognosis and management of posttransplant infections.

Indexed as

Postoperative ComplicationsAgedCD8-Positive T-LymphocytesFemaleFollow-Up StudiesHepatitis A Virus Cellular Receptor 2HumansImmunologic MemoryInfectionsLiver TransplantationLongitudinal StudiesMaleMiddle AgedPilot ProjectsPrognosisProgrammed Cell Death 1 ReceptorHAVCR2 protein, humanHepatitis A Virus Cellular Receptor 2PDCD1 protein, humanProgrammed Cell Death 1 Receptorcell death: exhaustioncostimulationimmunobiologyinfectious diseaseliver disease: infectiousliver transplantation/hepatologyT cell biologytranslational research/science

Identifiers

PMID29068155
PMCPMC5790618
OpenAlexW2766441912

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.